Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04447118
Title Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy (PYRAMID-1)
Acronym PYRAMID-1
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Jiangsu HengRui Medicine Co., Ltd.
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUS

No variant requirements are available.